Who
Kevin Lobo
Director
Company insider
Files Form 4 as: Director, GE HealthCare Technologies; Chair and CEO, Stryker; Director, Parker-Hannifin.
In numbers
- Trades disclosed
- 142
- Buys
- 2
- Sells
- 12
- Bought
- $1.4M
- Sold
- $114.4M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 26 Apr 2011
- Last trade
- 22 May 2026
- Last filed
- 26 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 May 2026filed 26 May 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Bought | $642K10,000 at $64.18 | filing |
| 22 May 2026filed 26 May 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Bought | $642K10,000 at $64.18 | filing |
| 7 May 2026filed 11 May 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —3,586 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —3,586 at $0.00 | filing |
| 21 Mar 2026filed 24 Mar 2026 | SYK StrykerMedical Devices | SEC FORM 4 Code M | —1,452 at $0.00 | filing |
| 21 Mar 2026filed 24 Mar 2026 | SYK StrykerMedical Devices | SEC FORM 4 Code F | $8.9M26,492 at $335.67 | filing |
| 21 Mar 2026filed 24 Mar 2026 | SYK Strykeroption or derivative · Medical Devices | SEC FORM 4 Code M | —1,452 at $0.00 | filing |
| 21 Mar 2026filed 24 Mar 2026 | SYK Strykeroption or derivative · Medical Devices | SEC FORM 4 Code M | —1,452 at $0.00 | filing |
| 21 Mar 2026filed 24 Mar 2026 | SYK StrykerMedical Devices | SEC FORM 4 Code M | —1,452 at $0.00 | filing |
| 21 Mar 2026filed 24 Mar 2026 | SYK StrykerMedical Devices | SEC FORM 4 Code F | $8.9M26,492 at $335.67 | filing |
| 13 Mar 2026filed 17 Mar 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —777 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —777 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | SYK StrykerMedical Devices | SEC FORM 4 Code A | —50,332 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | SYK StrykerMedical Devices | SEC FORM 4 Code A | —50,332 at $0.00 | filing |
| 6 Feb 2026filed 6 Feb 2026 | SYK StrykerMedical Devices | SEC FORM 4 Code M | $20.0M206,955 at $96.64 | filing |
| 6 Feb 2026filed 6 Feb 2026 | SYK StrykerMedical Devices | SEC FORM 4 Code F | $48.0M132,410 at $362.42 | filing |
| 6 Feb 2026filed 6 Feb 2026 | SYK Strykeroption or derivative · Medical Devices | SEC FORM 4 Code M | —206,955 at $0.00 | filing |
| 6 Feb 2026filed 6 Feb 2026 | SYK Strykeroption or derivative · Medical Devices | SEC FORM 4 Code M | —206,955 at $0.00 | filing |
| 6 Feb 2026filed 6 Feb 2026 | SYK StrykerMedical Devices | SEC FORM 4 Code M | $20.0M206,955 at $96.64 | filing |
| 6 Feb 2026filed 6 Feb 2026 | SYK StrykerMedical Devices | SEC FORM 4 Code F | $48.0M132,410 at $362.42 | filing |
News
Analyzing GE HealthCare Technologies (NASDAQ:GEHC) & AxoGen (NASDAQ:AXGN)GEHC · tickerreport.com · 21 Oct 2026Stock Traders Buy High Volume of Call Options on GE HealthCare Technologies (NASDAQ:GEHC)GEHC · dailypolitical.com · 12 Oct 2026
0 headlines in the last 90 days name Kevin Lobo; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.